Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 10, 2007 - Issue 5-6
52
Views
14
CrossRef citations to date
0
Altmetric
Articles

Potentiation of arsenic neurotoxicity by folate deprivation: Protective role of S-adenosyl methionine

&
Pages 199-204 | Published online: 05 Sep 2013

References

  • Anderton BH, Breinburg D, Downes MJ, Green PJ, Tomlinson BE, Ulrich J, Wood JN, Kahn J. 1982. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298:84–86.
  • Aposhian HV. 1997. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37:397–419.
  • Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML. 2003. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193:1–8.
  • Black MM, Lee VM-Y. 1988. Phosphorylation of neurofilament proteins in intact neurons: Demonstration ofphosphorylation in cell bodies and axons. J Neurosci 8:3296–3305.
  • Chan WK-C, Dickerson A, Otriz D, Pimenta A, Moran C, Malik K, Motil J, Snyder S, Pant HC, Shea TB. 2004. Mitogen activated protein kinase regulates neurofilament axonal transport. J Cell Sci 117:4629–4642.
  • Chattopadhyay S, Bhaumik S, Nag Chaudhury A, S. 2002a. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol Lett 128:73–84.
  • Chattopadhyay S, Bhaumik S, Purkayastha M, Basu S, Chaudhuri AN, Gupta SD. 2002b. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol Lett 136:65–76.
  • Chen J, Zhou J, Feng Y, Wang J. 2005. Effect of GSK-3 overactivation on neurofilament phosphorylation. J Huazhong Univ Sci Technolog Med Sci 25:375–377.
  • Cooper KL, Liu KJ, Hudson LG. 2006. Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicol Appl Pharmacol 2006 [Epub ahead of print].
  • Crandall LZ, Vorce RL. 2002 Nov 15. Differential effects of arsenic on folate binding protein 2 (Folbp2) null and wild type fibroblasts. Toxicol Lett 136(1):43–54.
  • DeFuria J, Chen P, Shea TB. 2006. Divergent effects ofthe MEKK- 1/JNK pathway on NB2a/d1 differentiation: Some activity is required for outgrowth and stabilization of neurites but overactivation inhibits both phenomena. Brain Res 1123:20–26.
  • Eizirik DL, Spencer P, Kisby GE. 1996. Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem Pharmacol 51: 1585–1591.
  • Ferm VH, Hanlon DP. 1986. Arsenate-induced neural tube defects not influenced by constant rate administration of folic acid. Pediatr Res 20:761–762.
  • Gabbianelli R, Ferri A, Rotilio G, Carri MT. 1999. Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyoptropic lateral sclerosis. J Neurochem 73:1175–1180.
  • Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH. 2005. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113: 1683–1688.
  • Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Chen Y, Levy D, Factor-Litvak P, Graziano JH. 2006. Folate and arsenic metabolism: A double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84:1093–1101.
  • Gefrides LA, Bennett GD, Finnell RH. 2002. Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in splotch mice. Teratology 65:63–69.
  • Giafis N, Katsoulidis E, Sassano A, Tallman MS, Higgins LS, Nebreda AR, Davis RJ, Platanias LC. 2006. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Cancer Res 66: 6763–6771.
  • Ho PI, Ortiz D, Rogers E, Shea TB. 2002. Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70:694–702.
  • Ho P, Ashline D, Dhitavat S, Ortiz D, Collins SC, Rogers E, Shea TB. 2003. Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol Dis 14:32–42.
  • Julien J-P, Mushynski WE. 1998. Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol 61:1–20.
  • Jung C, Yabe J, Wang F-S, Shea TB. 1998. Neurofilaments are present within axonal neurites before incorporation into triton- insoluble structures. Cell Motil Cytoskel 40:44–58.
  • Kajiguchi T, Yamamoto K, Iida S, Ueda R, Emi N, Naoe T. 2006. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines. Cancer Sci 97:540–545.
  • Kannan GM, Flora SJ. 2006. Combined administration of N-acetylcysteine and monoisoamyl DMSA on tissue oxidative stress during arsenic chelation therapy. Biol Trace Elem Res 2006 Apr 110(1):43–59.
  • Kannan-Thulasiraman P, Katsoulidis E, Tallman MS, Arthur JS, Platanias LC. 2006. Activation of the mitogen- and stress- activated kinase 1 by arsenic trioxide. J Biol Chem 281: 22446–22452.
  • Kim HJ, Kim M, Kim SH, Sung JJ, Lee KW. 2002. Alteration in intracellular calcium homeostasis reduces motor neuronal viability expressing mutated Cu/Zn superoxide dismutase through a nitric oxide/guanylyl cyclase cGMP cascade. Neuron 13:1131–1135.
  • Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20:6920–6926.
  • Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Roy G, Cutler RG, Kruman Y, Norman Haughey N, Lee J, Michele Evans M, Mattson MP. 2002. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22:1752–1762.
  • Li W, Chou IN. 1992. Effects ofsodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol 114:132–139.
  • Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ. 2002. A novel S-adenosyl-L- methionine: Arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795–10803.
  • Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP. 2004. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci 77:249–257.
  • Loenen WA. 2006. S-adenosylmethionine: Jack of all trades and master of everything? Biochem Soc Trans 34:330–333.
  • Mattson MM, Shea TB. 2002. Folate and homocysteine in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146.
  • Mizrahi EH, Jacobsen DW, Debanne SM, Traore F, Lerner AJ, Friedland RP, Petot GJ. 2003. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in ad and healthy aging. J Nutr Health Aging 7(3):160–165.
  • Modi M, Kaul RK, Kannan GM, Flora SJ. 2006. Co-administration of zinc and N-acetylcysteine prevents arsenic-induced tissue oxidative stress in male rats. J Trace Elem Med Biol 20(3): 197–204, Epub 2006 Apr 17.
  • Nagaraja TN, Desiraju T. 1993. Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam Toxicol 50:100–107.
  • Namgugn U, Xia Z. 2001. Arsenic induces apoptosis in rat cerebellar neurons via activation ofJNK3 and p38 MAP kinases. Toxicol Appl Pharmacol 174:130–138.
  • Pant HC, Veeranna. 1995. Neurofilament phosphorylation. Biochem Cell Biol 73:575–592.
  • Piga R, Saito Y, Yoshida Y, Niki E. 2006. Cytotoxic effects ofvarious stressors on PC12 cells: Involvement of oxidative stress and effect of antioxidants. Neurotoxicology, 2006 Jul 21 [Epub ahead of print].
  • Potin S, Bertoglio J, Breard J. 2007. Involvement of a Rho-ROCK- JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells. FEBS Lett 581:118–124.
  • Ramirez T, Garcia-Montalvo V, Wise C, Cea-Olivares R, Poirier LA, Herrera LA. 2003. S-adenosyl-L-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells. Mutat Res 528:61–74.
  • Rao M, Nixon RA. 2003 Jul. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: A review. Neurochem Res 28(7):1041–1047.
  • Schuliga M, Chouchane S, Snow ET. 2002. Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol Sci 70:183–192.
  • Shalat SL, Walker DB, Finnell RH. 1996. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health 48(3):253–272, 1996 June 28.
  • Shea TB, Rogers E. 2002a. Homocysteine as a risk factor for Alzheimer’s disease. N Engl J Med 346, 2007.
  • Shea TB, Rogers E. 2002b. Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: Augmentation by vitamin E. Mol Brain Res 108:1–6.
  • Shea TB, Rogers E, Ortiz D, Sheu M-S. 2002. Apolipoprotein-E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. J Free Radic Biol Med 33:1115–1120.
  • Shibata N. 2001. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 21:82–92.
  • Strong M. 2003. The basics of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 5542:1–36.
  • Sung JJ, Kim HJ, Choi-Kwon S, Lee J, Kim M, Lee KW. 2002. Homocysteine induces oxidative cytotoxicity in Cu,Zn-super- oxide dismutase mutant motor neuronal cell. Neuroreport 13: 377–381.
  • Tchantchou F, Graves M, Ortiz D, Shea TB. 2006. S-adenosyl methionine: A link between nutritional and genetic risk factors in Alzheimer’s disease. J Nutr Health Aging 10:541–544.
  • Tjiattas L, Ortiz D, Sirikarnt Dhivant S, Mitton K, Rogers E, Shea TB. 2004. Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell 3:71–76.
  • Vahidnia A, Romijn F, Tiller M, van der Voet GB, de Wolff FA. 2006. Arsenic-induced toxicity: Effect on protein composition in sciatic nerve. Hum Exp Toxicol 25(11):667–674, 2006 Nov.
  • van Bergen en Henegouwen PM, Linnemans AM. 1987. Heat shock gene expression and cytoskeletal alterations in mouse neuroblastoma cells. Exp Cell Res 171:367–375.
  • Van Den Bosch L, Vandenberghe W, Klaassen H, Van Houtte E, Robberecht W. 2000. Ca(2 + )-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 180 (1–2):29–34, 2000Nov.
  • White F, Nicoll JA, Roses AD, Horsburgh K. 2001. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis 8:611–625.
  • Wlodarczyk B, Spiegelstein O, Gelineau-van Waes J, Vorce RL, Lu X, Le CX, Finnell RH. 2001. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol Appl Pharmacol 177:238–246.
  • Wlodarczyk BJ, Cabrera RM, Hill DS, Bozinov D, Zhu H, Finnell RH. 2006. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology 27:547–557.
  • Yabe JT, Chylinski TM, Wang F-S, Pimenta AF, Kattar SD, Linsley M-D, Chan WK-H, Shea TB. 2001. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling and axonal transport rate in growing axonal neurites. J Neurosci 21:2195–2205.
  • Yoshida T, Yamauchi H, Fan Sun G. 2004. Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicol Appl Pharmacol 198:243–252.
  • Yoshino Y. 1984. Possible involvement of folate cycle in the pathogenesis of amyotrophic lateral sclerosis. Neurochem Res 9: 387–391.
  • Zakharyan RA, Ayala-Fierro F, Cullen WR, Carter DM, Aposhian HV. 1999. Enzymatic methylation of arsenic compounds VII. monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol Appl Pharmacol 158:9–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.